Risk factors for lateral lymph node metastasis in T1 stage papillary thyroid carcinoma.
作者信息
Dai Yunlong, Feng Qingbo
机构信息
Department of Hepatobiliary Surgery, Wenjiang District People's Hospital of Chengdu, Chengdu, China.
Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
出版信息
Gland Surg. 2024 Jun 30;13(6):1152-1153. doi: 10.21037/gs-24-143. Epub 2024 Jun 13.
Abstract
摘要
相似文献
1
Risk factors for lateral lymph node metastasis in T1 stage papillary thyroid carcinoma.T1期甲状腺乳头状癌侧方淋巴结转移的危险因素
Gland Surg. 2024 Jun 30;13(6):1152-1153. doi: 10.21037/gs-24-143. Epub 2024 Jun 13.
2
Unilateral Tnm T1 And T2 Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: Total Thyroidectomy or Lobectomy?单侧 Tnm T1 和 T2 期甲状腺乳头状癌伴颈侧淋巴结转移：甲状腺全切除术还是腺叶切除术？
Endocr Pract. 2020 Oct;26(10):1085-1092. doi: 10.4158/EP-2020-0125.
3
Establishing a prediction model for lateral neck lymph node metastasis in patients with papillary thyroid carcinoma.建立甲状腺乳头状癌患者颈侧区淋巴结转移的预测模型。
Sci Rep. 2018 Nov 26;8(1):17355. doi: 10.1038/s41598-018-35551-9.
4
The efficacy of lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma.甲状腺乳头状癌侧颈部淋巴结前哨活检的疗效。
World J Surg. 2011 Dec;35(12):2675-82. doi: 10.1007/s00268-011-1254-9.
5
The characteristics and risk factors of central compartment lymph node metastasis in cN0 papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.合并桥本甲状腺炎的cN0期乳头状甲状腺癌中央区淋巴结转移的特征及危险因素
Gland Surg. 2020 Dec;9(6):2026-2034. doi: 10.21037/gs-20-699.
6
Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients.甲状腺乳头状癌侧颈部淋巴结转移的危险因素分析：一项 830 例患者的回顾性研究。
World J Surg Oncol. 2024 Jun 21;22(1):162. doi: 10.1186/s12957-024-03455-w.
7
[Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].[甲状腺乳头状癌侧颈部淋巴结转移的危险因素分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jul;33(7):603-606. doi: 10.13201/j.issn.1001-1781.2019.07.007.
8
Nomogram for predicting central lymph node metastasis in T1-T2 papillary thyroid cancer with no lateral lymph node metastasis.用于预测无侧方淋巴结转移的 T1-T2 期甲状腺乳头状癌中央区淋巴结转移的列线图。
Front Endocrinol (Lausanne). 2023 Jan 19;14:1112506. doi: 10.3389/fendo.2023.1112506. eCollection 2023.
9
A Meta-analysis of Central Lymph Node Metastasis for Predicting Lateral Involvement in Papillary Thyroid Carcinoma.一项关于中央淋巴结转移预测甲状腺乳头状癌侧方受累的Meta分析。
Otolaryngol Head Neck Surg. 2015 Nov;153(5):731-8. doi: 10.1177/0194599815601412. Epub 2015 Aug 25.
10
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.
本文引用的文献
1
Analysis of risk factors for lateral lymph node metastasis in T1 stage papillary thyroid carcinoma: a retrospective cohort study.T1期甲状腺乳头状癌侧方淋巴结转移危险因素分析：一项回顾性队列研究
Gland Surg. 2024 Mar 27;13(3):314-324. doi: 10.21037/gs-23-470. Epub 2024 Mar 20.
2
Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies.变应原免疫治疗（APAIT）中的依从性和持久性：回顾性研究报告清单。
Allergy. 2023 Aug;78(8):2277-2289. doi: 10.1111/all.15723. Epub 2023 Apr 27.
3
Editorial: Recent advances in papillary thyroid carcinoma: Progression, treatment and survival predictors.社论：甲状腺乳头状癌的最新进展：进展、治疗及生存预测因素
Front Endocrinol (Lausanne). 2023 Mar 7;14:1163309. doi: 10.3389/fendo.2023.1163309. eCollection 2023.
4
Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.当代高细胞型甲状腺乳头状癌的评估与管理。
Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):351-357. doi: 10.1097/MED.0000000000000559.
5
Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.甲状腺乳头状癌的基因改变与临床病理特征之间的关系。
Med Mol Morphol. 2019 Dec;52(4):181-186. doi: 10.1007/s00795-019-00217-6. Epub 2019 Feb 20.
Zotero 插件